Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Spyglass Pharma Inc (SGP)

Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SpyGlass Pharma Appoints Shannon Treviño as General Counsel GlobeNewswire - Mon Jun 15, 7:00AM CDT

ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing GlobeNewswire - Tue Jun 2, 7:00AM CDT

ALISO VIEJO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced the appointment of Mike Pinder as...

SGP : 19.77 (-4.77%)
SpyGlass Pharma to Participate in Upcoming Investor Conferences GlobeNewswire - Thu May 21, 7:00AM CDT

ALISO VIEJO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System GlobeNewswire - Mon May 18, 7:00AM CDT

ALISO VIEJO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma), a late-stage biopharmaceutical company, today announced that the American Medical Association’s...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates GlobeNewswire - Thu May 14, 3:05PM CDT

Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027. Topline 12-month data from the...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update GlobeNewswire - Thu Mar 26, 3:05PM CDT

Successfully completed Initial Public Offering (IPO) in February 2026, raising $172.5 million and listing on Nasdaq. Reported positive topline 12-month data from Phase 1/2 trial of the Bimatoprost Drug...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System GlobeNewswire - Mon Mar 9, 7:00AM CDT

97% of patients who received the BIM-IOL System off all topical IOP-lowering therapy at 12-months 100% of BIM-IOL System patients achieved 20/32 or better BCDVA and a mean BCDVA equivalent to 20/20 vision,...

SGP : 19.77 (-4.77%)
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit GlobeNewswire - Wed Mar 4, 7:00AM CST

ALISO VIEJO, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced that members of the executive...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares GlobeNewswire - Mon Feb 9, 3:05PM CST

ALISO VIEJO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the closing of its initial...

SGP : 19.77 (-4.77%)
SpyGlass Pharma Announces Pricing of Initial Public Offering GlobeNewswire - Thu Feb 5, 6:00PM CST

ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial...

SGP : 19.77 (-4.77%)

Barchart Exclusives

Alibaba Stock Just Got Apple’s Biggest AI Endorsement. This Could Be a Game Changer for BABA. Barchart - Sun Jul 19, 2:30PM CDT
Apple's reported AI partnership with Alibaba is boosting confidence in the company's AI strategy as analysts see 58% upside ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.